Should I buy ACADIA Pharmaceuticals stock?

Should I buy ACADIA Pharmaceuticals stock?

Out of 14 analysts, 2 (14.29%) are recommending ACAD as a Strong Buy, 5 (35.71%) are recommending ACAD as a Buy, 7 (50%) are recommending ACAD as a Hold, 0 (0%) are recommending ACAD as a Sell, and 0 (0%) are recommending ACAD as a Strong Sell. What is ACAD’s earnings growth forecast for 2022-2024?

Why did ACADIA Pharmaceuticals stock drop?

ACAD Stock Plummets on Thumbs Down From FDA Committee On Friday, the Psychopharmacologic Drugs Advisory Committee voted down Acadia Pharmaceutical’s Nuplazid drug in a 9-3 vote, following a “lengthy discussion.” The panel’s decision was based on a lack of evidence supporting the treatment.

Will ACAD go back up?

Based on our forecasts, a long-term increase is expected, the “ACAD” stock price prognosis for 2027-05-26 is 16.569 USD. With a 5-year investment, the revenue is expected to be around +2.72%. Your current $100 investment may be up to $102.72 in 2027.

Why is ACAD stock down?

Acadia Pharmaceuticals Crashes After FDA Panel Votes Down Its Alzheimer’s Psychosis Drug. Food and Drug Administration experts voted against recommending Acadia Pharmaceuticals’ (ACAD) Alzheimer’s disease psychosis drug, leading ACAD stock to plummet Tuesday. On today’s stock market, ACAD stock collapsed 33.3% to 13.01 …

What drugs does Acadia make?

Acadia’s business largely revolves around pimavanserin, which was first approved by the FDA in 2016 to treat the hallucinations and delusions associated with Parkinson’s disease psychosis. Sold as Nuplazid, the drug was responsible for all of Acadia’s $442 million in total revenue last year.

How many employees does Acadia Pharmaceuticals have?

570
Acadia Pharmaceuticals

Formerly	Receptor Technologies
Total equity	US$699.14 million (2019)
Number of employees	570 (June 30, 2020)
Website	acadia.com
Footnotes / references

When did Nuplazid launch?

NUPLAZID was approved by the U.S. Food and Drug Administration ( FDA ) on April 29, 2016 for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. NUPLAZID is the first and only drug approved by the FDA for this indication.

What does Acadia Pharma do?

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders.

How much does Nuplazid cost?

The cost for Nuplazid oral capsule 34 mg is around $4,404 for a supply of 30 capsules, depending on the pharmacy you visit.

Is Nuplazid approved by the FDA?

FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) – The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis – Acadia Pharmaceuticals Inc. Acadia is trailblazing breakthroughs in neuroscience to elevate life.

Is Acadia Pharmaceuticals a good company to work for?

Acadia Pharmaceuticals is ranked #100 on the Best Health Care Companies to Work For in California list. Zippia’s Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Are there any new drugs for Parkinson’s?

FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease. The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.

Is there a generic version of NUPLAZID?

No. There is currently no therapeutically equivalent version of Nuplazid available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nuplazid. These medications may be counterfeit and potentially unsafe.

How much does NUPLAZID cost?

How long has NUPLAZID been on the market?

Nuplazid (pimavanserin) was approved by the U.S. Food and Drug Administration (FDA) in April 2016 under the agency’s Breakthrough Therapy Designation, one of four expedited review programs at FDA, applicable to drugs that have shown substantial improvement over existing treatments in early clinical data.

Where is Acadia Pharmaceuticals located?

San Diego, California
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

How much does NUPLAZID cost in Canada?

Nuplazid (pimavanserin) price in other currencies*

Package	Euro	Canadian dollar
30 tablets of 34 mg	7761 EUR	10465 CAD

How much does a NUPLAZID pill cost?

The cost for Nuplazid oral capsule 34 mg is around $4,404 for a supply of 30 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.